On ECHEMI
Home > Drugs > CSPC NBP Pharmaceutical Co., Ltd.
CSPC NBP Pharmaceutical Co., Ltd.
  • Founded in:

    2003-04-23
  • Country:

    China China
  • Address:

    No. 88, Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    911301007468953573
  • Registered Funds:

    413.5943 million yuan
  • Website:

  • Email:

Related Drugs
Yiganling Soft Capsules
Silymarin.
Name Description Content CAS NO. Registered Holders
Silymarin

No specific pharmacological information is provided

More

No specific pharmacological information is provided

65666-07-1 13
Isosorbide Mononitrate Sodium Chloride Injection
Name Description Content CAS NO. Registered Holders
Isosorbide 5-mononitrate

Dilates blood vessels, used to prevent and treat angina

More

Dilates blood vessels, used to prevent and treat angina

16051-77-7 22
Sodium chloride

7647-14-5 43
Ibuprofen soft capsules
Each tablet of this product contains the main ingredient ibuprofen 0.2g, and the auxiliary materials are polyethylene glycol 400, potassium hydroxide, gelatin, glycerin, water
Name Description Content CAS NO. Registered Holders
Ibuprofen

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects

0.2g 15687-27-1 54
Polyethylene Glycol

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

25322-68-3 52
Potassium hydroxide

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

1310-58-3 11
Gelatin

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

9000-70-8 47
Glycerol

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

56-81-5 61
Water

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

7732-18-5 11
Ibuprofen soft capsules
Each tablet of this product contains the main ingredient ibuprofen 0.2g, and the auxiliary materials are polyethylene glycol 400, potassium hydroxide, gelatin, glycerin, water
Name Description Content CAS NO. Registered Holders
Ibuprofen

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects

0.2g 15687-27-1 54
Polyethylene Glycol

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

25322-68-3 52
Potassium hydroxide

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

1310-58-3 11
Gelatin

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

9000-70-8 47
Glycerol

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

56-81-5 61
Water

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

More

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

7732-18-5 11
Butylphthalide soft capsule
Butylphthalide.
Name Description Content CAS NO. Registered Holders
3-N-Butylphthalide

This product has the same structure as L-Apigenin A extracted from celery seeds and is a synthetic racemate. It has anti-cerebral ischemia effect, can block multiple pathological links of brain damage caused by ischemic stroke, significantly reduce the infarct area of local cerebral ischemia in rats, reduce brain edema, improve brain energy metabolism and microcirculation and blood flow in ischemic brain areas, inhibit nerve cell apoptosis, and has anti-cerebral thrombosis and anti-platelet aggregation effects. The above-mentioned pharmacodynamic effects may be produced by reducing the content of arachidonic acid, increasing the levels of NO and PGI2 in the cerebral endothelium, inhibiting the release of glutamate, reducing the concentration of intracellular calcium, inhibiting free radicals and increasing the activity of antioxidant enzymes.

More

This product has the same structure as L-Apigenin A extracted from celery seeds and is a synthetic racemate. It has anti-cerebral ischemia effect, can block multiple pathological links of brain damage caused by ischemic stroke, significantly reduce the infarct area of local cerebral ischemia in rats, reduce brain edema, improve brain energy metabolism and microcirculation and blood flow in ischemic brain areas, inhibit nerve cell apoptosis, and has anti-cerebral thrombosis and anti-platelet aggregation effects. The above-mentioned pharmacodynamic effects may be produced by reducing the content of arachidonic acid, increasing the levels of NO and PGI2 in the cerebral endothelium, inhibiting the release of glutamate, reducing the concentration of intracellular calcium, inhibiting free radicals and increasing the activity of antioxidant enzymes.

6066-49-5 20
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.